These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26618210)

  • 1. WORLD HEPATITIS SUMMIT HARNESSES GLOBAL MOMENTUM TO ELIMINATE VIRAL HEPATITIS.
    Cent Eur J Public Health; 2015 Sep; 23(3):272. PubMed ID: 26618210
    [No Abstract]   [Full Text] [Related]  

  • 2. Who: four ways to reduce hepatitis infections in people who inject drugs.
    Cent Eur J Public Health; 2012 Sep; 20(3):207. PubMed ID: 23285521
    [No Abstract]   [Full Text] [Related]  

  • 3. Global hepatitis C elimination: an investment framework.
    Pedrana A; Howell J; Scott N; Schroeder S; Kuschel C; Lazarus JV; Atun R; Baptista-Leite R; 't Hoen E; Hutchinson SJ; Aufegger L; Peck R; Sohn AH; Swan T; Thursz M; Lesi O; Sharma M; Thwaites J; Wilson DP; Hellard M
    Lancet Gastroenterol Hepatol; 2020 Oct; 5(10):927-939. PubMed ID: 32730786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New WHO guidance for country validation of viral hepatitis B and C elimination.
    Easterbrook P; Luhmann N; Newman M; Walsh N; Lesi O; Doherty M
    Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):778-780. PubMed ID: 34384530
    [No Abstract]   [Full Text] [Related]  

  • 5. Eliminating hepatitis from the Eastern Mediterranean Region.
    Fikri M
    East Mediterr Health J; 2017 Aug; 23(7):459-460. PubMed ID: 28853128
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fighting viral hepatitis B and C in Africa. Focus on Benin].
    Kodjoh N
    Med Sante Trop; 2015; 25(2):141-4. PubMed ID: 26039152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. This is hepatitis--it is closer than you think.
    Fung J; Yuen MF
    Indian J Med Res; 2012 Jul; 136(1):3-6. PubMed ID: 22885256
    [No Abstract]   [Full Text] [Related]  

  • 8. Mobilising a global response to hepatitis: Lessons learned from the HIV movement.
    Taaffe J; Wilson D
    Glob Public Health; 2018 Apr; 13(4):473-488. PubMed ID: 27748158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral hepatitis in the field of dentistry. I. The risk for health workers].
    Nardi G
    Minerva Stomatol; 1982; 31(6):743-53. PubMed ID: 6819437
    [No Abstract]   [Full Text] [Related]  

  • 10. The risk of acquiring hepatitis A and B among travelers in selected Eastern and Southern Europe and non-European Mediterranean countries: review and consensus statement on hepatitis A and B vaccination.
    Nothdurft HD; Dahlgren AL; Gallagher EA; Kollaritsch H; Overbosch D; Rummukainen ML; Rendi-Wagner P; Steffen R; Van Damme P;
    J Travel Med; 2007; 14(3):181-7. PubMed ID: 17437475
    [No Abstract]   [Full Text] [Related]  

  • 11. Progress towards elimination goals for viral hepatitis.
    Cox AL; El-Sayed MH; Kao JH; Lazarus JV; Lemoine M; Lok AS; Zoulim F
    Nat Rev Gastroenterol Hepatol; 2020 Sep; 17(9):533-542. PubMed ID: 32704164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The danger of viral hepatitis involvement in hemophilia patients].
    Epifanov NS
    Ter Arkh; 1990; 62(11):135-7. PubMed ID: 2128859
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis B and C: prevention is better than cure.
    Arif A
    J Pak Med Assoc; 2013 Feb; 63(2):154-5. PubMed ID: 23894885
    [No Abstract]   [Full Text] [Related]  

  • 14. Towards a hepatitis-free Egypt: is this achievable? (Editorial).
    Doss W; Hermez J; Atta H; Jabbour J
    East Mediterr Health J; 2018 Sep; 24(7):609-610. PubMed ID: 30370918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B: a serious public health threat. Viral Hepatitis Prevention Board.
    Grob P; Hallauer J; Kane M; McCloy E; Meheus A; Roure C; Van Damme P
    Vaccine; 1998 Nov; 16 Suppl():S1-2. PubMed ID: 9915023
    [No Abstract]   [Full Text] [Related]  

  • 16. Viral hepatitis.
    Deinhardt F; Abb J; Assaad F
    WHO Chron; 1983; 37(6):203-7. PubMed ID: 6424338
    [No Abstract]   [Full Text] [Related]  

  • 17. Vaccination against hepatitis B and C: towards therapeutic application.
    Inchauspe G; Bach G; Martin P; Bonnefoy JY
    Int Rev Immunol; 2009; 28(1):7-19. PubMed ID: 19241251
    [No Abstract]   [Full Text] [Related]  

  • 18. [Not Available].
    Nau JY
    Rev Med Suisse; 2017 May; 13(563):1066-1067. PubMed ID: 28636300
    [No Abstract]   [Full Text] [Related]  

  • 19. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis Part II. Viral hepatitis B, C, and D.
    Gurevich I
    Heart Lung; 1993; 22(5):450-6; quiz 457-8. PubMed ID: 8226010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.